| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 47,490 | 55,748 | 62,786 | 78,631 | | Cost of Revenue | 30,868 | 35,086 | 38,760 | 48,302 | | | Gross Profit | 16,622 | 20,662 | 24,026 | 30,329 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,876 | 13,468 | 18,078 | 14,092 | | Non Recurring |
-
|
-
|
-
| 23,500 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,746 | 7,194 | 5,948 | (7,263) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,234 | 31 | 219 | 230 | | Earnings Before Interest And Taxes | 5,339 | 7,778 | 6,167 | (7,033) | | Interest Expense | 159 | 232 | 250 | 411 | | Income Before Tax | 5,180 | 7,546 | 5,917 | (7,444) | | Income Tax Expense | 1,101 | 2,658 | 2,097 | 1,246 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,079 | 4,888 | 3,820 | (8,690) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (28) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,079 | 4,888 | 3,820 | (8,718) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,079 | $4,888 | $3,820 | ($8,718) |
|
1.52% Nasdaq 0.00%
Income Statement
